Over the last 10 years the syndrome of severe acute renal failure has progressively changed in its epidemiology. It is now most frequently seen in critically ill patients, typically in the context of sepsis and multiorgan failure. This epidemiologic change has meant that intensive care physicians and nephrologists must now work in close cooperation at all times and must take many com plex issues of prevention, pathogenesis, and management into account that they did not previously have to tackle. Simultaneously, the last 10 years have seen the development of major technical and conceptual changes in the field of renal replacement therapy. There are now previously unavailable therapeutic options that provide physicians with a flexible and rapidly evolving armamentarium. The nutrition of these patients, previously limited by the par tial efficacy of renal replacement therapies, has also become more aggressive and more in tune with the needs of critically ill patients. Increased understanding of the pathogenesis of the multi organ failure syndrome has focused on the role of many soluble "mediators of injury" (cytokines, leukotrienes, prostanoids etc.). These molecules are likely to participate in the pathogenesis of acute renal failure. Their generation and disposal is also affected by different techniques of artificial renal support."

This book presents contributions from leading international experts in the field of nephrology. Each chapter is independent and discusses nephrology in the author's country, including the history of nephrology development, kidney disease epidemiology, clinical nephrology, dialysis practice in acute and chronic renal failure settings (hemodialysis, hemodiafiltration, peritoneal dialysis), pediatric nephrology, and kidney transplantation. In addition, the book covers topics such as the job market for nephrologists, reimbursement, nephrology education, and the number of professionals in the private and public sectors. With 53 chapters and more than 300 authors from all continents offering a unique perspective on nephrology practice, it provides a much-needed information source for nephrologists around the globe. The reader will be able to travel through "Nephrology Worldwide", a pleasant reading experience with not only relevant information and updated data, but also a comprehensive look at the history, countries' peculiarities, and a critical analysis of the scenario of nephrology and renal replacement therapy. A valuable resource for healthcare professionals and other stakeholders interested in learning about the status quo of Nephrology Worldwide. "Both the failings and the successes are outlined in a way that should make this book a compelling read, not just for the well-informed renal physician, but also for planners and policy makers whose thinking and actions are integral to the way we practice medicine." - Sir Peter J. Ratcliffe, Nephrologist and 2019 Nobel Prize Winner More information on the Nephrology Worldwide initiative can be found at www.nephrologyworldwide.com.

Continuous Renal Replacement Therapy (CRRT) is the standard of care for management of critically ill patients with acute renal failure. Part of the Pittsburgh Critical Care series, Continuous Renal Replacement Therapy provides concise, evidence-based, bedside guidance about this treatment modality, offering quick reference answers to clinicians' questions about treatments and situations encountered in daily practice. Organized into sections on theory, practice, special situations, and organizational issues, this volume provides a complete view of CRRT theory and practice. Tables summarize and highlight key points, and key studies and trials are included in each chapter. The second edition has been updated to include a new chapter on the use of biomarkers to aid in patient selection and timing, extensive revisions on terminology and nomenclature to match current standards, and the most up-to-date information on newly developed CRRT machines.

This book with its most comprehensive and illuminating chapters covers all the relevant areas of hemodialysis practice including access for hemodialysis, hemodialysis modeling and membranes, timing of hemodialysis, infections in hemodialysis, the application of hemodialysis in extra-renal disease, the various formats of hemodialysis from nocturnal through SLED to apheresis and the wearable artificial kidney, convective hemodialysis methodologies, and various clinical aspects of hemodialysis including protein-calorie-malnutrition, inflammation, haemoglobin stability and sleep disorders in ESRD patients and so on. Furthermore, the inclusion of such new topics as the syndrome of rapid-onset end stage renal disease (SORO-ESRD), and the place of reduced HBV testing among ESRD patients in regions with less de novo HBV incidence to cut down on costs of delivery of hemodialysis care without loss of quality of care, are new paradigms that would play stronger roles in hemodialysis care, well into the 21st century.